Last reviewed · How we verify
Placebo to match Hydroxycarbamide — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo to match Hydroxycarbamide (Placebo to match Hydroxycarbamide) — Suzhou Zelgen Biopharmaceuticals Co.,Ltd. This is a placebo formulation designed to match the appearance and administration of hydroxycarbamide for use as a control in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo to match Hydroxycarbamide TARGET | Placebo to match Hydroxycarbamide | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo to match Hydroxycarbamide CI watch — RSS
- Placebo to match Hydroxycarbamide CI watch — Atom
- Placebo to match Hydroxycarbamide CI watch — JSON
- Placebo to match Hydroxycarbamide alone — RSS
Cite this brief
Drug Landscape (2026). Placebo to match Hydroxycarbamide — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-hydroxycarbamide. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab